fingolimod hydrochloride has been researched along with Cataract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillam, M; Richardson, T | 1 |
| Barker, DA; Botchwey, EA; Das, A; Lau, CM; Lin, Y; Wang, T | 1 |
2 other study(ies) available for fingolimod hydrochloride and Cataract
| Article | Year |
|---|---|
Bilateral fingolimod-associated macular oedema development after cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Fingolimod Hydrochloride; Humans; Macular Edema | 2021 |
Delivery of bioactive lipids from composite microgel-microsphere injectable scaffolds enhances stem cell recruitment and skeletal repair.
Topics: Abnormalities, Multiple; Animals; Bone Regeneration; Cataract; Cell Differentiation; Cell Movement; Cornea; Female; Fingolimod Hydrochloride; Gels; Hypogonadism; Intellectual Disability; Lipids; Mice; Mice, Inbred C57BL; Microcephaly; Microspheres; Optic Atrophy; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine; Stem Cells; Tissue Scaffolds | 2014 |